Cerapedics Expands PearlMatrix P-15 Approval for More Spinal Surgeries Cerapedics' PearlMatrix P-15 receives FDA approval for additional surgical uses, enhancing options for patients with degenerative disc disease.

Cerapedics Expands PearlMatrix P-15 Approval for More Spinal Surgeries #United_States #Westminster #Cerapedics #PearlMatrix #P-15_Peptide

Cerapedics Publishes Successful 24-Month ASPIRE Study Results on PearlMatrix Bone Graft Cerapedics reveals groundbreaking 24-month results from the ASPIRE study on PearlMatrix P-15, demonstrating superior clinical outcomes for bone grafts.

Cerapedics Publishes Successful 24-Month ASPIRE Study Results on PearlMatrix Bone Graft #USA #Westminster #Cerapedics #PearlMatrix #P-15_Peptide

Cerapedics Marks Milestone with First U.S. Patient Treated Using PearlMatrix Bone Graft After FDA Approval Cerapedics announces the successful treatment of the first patient in the U.S. with PearlMatrix Bone Graft, showcasing advancements in spinal fusion procedures.

Cerapedics Marks Milestone with First U.S. Patient Treated Using PearlMatrix Bone Graft After FDA Approval #United_States #Cerapedics #Bone_Graft #PearlMatrix #Louisville,_Colorado

Cerapedics Receives FDA Approval for PearlMatrix Bone Graft: A New Revolutionary Treatment for Lumbar Fusion Cerapedics has achieved FDA approval for its innovative PearlMatrix™ P-15 Peptide Enhanced Bone Graft, designed to accelerate bone growth in lumbar fusion surgeries.

Cerapedics Receives FDA Approval for PearlMatrix Bone Graft: A New Revolutionary Treatment for Lumbar Fusion #USA #Westminster #Cerapedics #PearlMatrix #P-15_Peptide